Financial Times loses Indian trade mark in “unprecedented” case

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Financial Times loses Indian trade mark in “unprecedented” case

India’s Intellectual Property Appellate Board (IPAB) has cancelled the Financial Times trade marks registered by both the British newspaper (FTUK) and Indian company Times Publishing House Limited (TPH) in a dispute between the two companies

Wide ranging battle

The IPAB’s ruling is part of a 19-year dispute between the two companies over the mark. FTUK applied to register the mark in March 1987 and received the registration in February 1994. In December 1993, TPH filed to rectify FTUK’s trade mark. However, TPH also received a registration for the mark in 2005, resulting in two Financial Times marks in the register.

Despite these and other legal actions, there was a syndication agreement for TPH to run FTUK’s content from 1993 until 2008.

Cancellation

IPAB found that FTUK had used its mark and that the mark was distinctive in India. It held that FTUK’s low circulation numbers was not dispositive of the distinctiveness issue and that it in fact had established a “formidable” and “enviable” trans-border reputation in its mark.

IPAB rejected TPH’s argument that FTUK lacked sufficient reputation in India, pointing to the syndication agreement between the parties.

The court reasoned that TPH would not have entered an agreement with just anybody, explained Anuradha Salhotra at Lall Lahiri & Salhotra. “It had to be with someone with reputation.”

The court also cancelled TPH’s trade mark on the grounds that it was registered dishonestly, saying the syndication agreement showed that it was aware of FTUK’s use of the mark.

Despite these findings, IPAB cancelled FTUK’s mark on the grounds that its trade mark application claimed continuous use since 1948, but there was only evidence of use since 1951.

Salhotra said she was surprised at IPAB’s reasoning for cancelling FTUK’s mark.

“The finding was totally in (FTUK’s) favour” except for the actual starting use date, said Salhotra, who added that the issue of the 1948 use date was not proper grounds to cancel the mark.

“IPAB should have looked at the date of application (in 1987) to decide whether the mark was distinctive then, not to 1948”, she explained, adding that this aspect of an otherwise solid decision was “unprecedented”.

Not done yet

The cancellations of both marks have been stayed pending appeal.

TPH’s counsel told Managing IP that the company believes IPAB’s holding should be overturned. Attorneys for FTUK declined to comment.

IPAB’s ruling ignored a previous 2002 suit between the parties that found the FTUK’s mark was not distinctive, said Hemant Singh of Inttl Advocare in New Delhi and counsel for TPH.

“The concept of trans-border reputation by itself may not be applicable in the case of a newspaper considering that there are common titles used by different publishers all over the world,” he explained, pointing to multiple newspapers named “Statesman” and “Telegraph” as examples.

In addition, Singh argued that FTUK failed to comply with the Press and Registration of Books Act, which governs newspapers, and therefore was not entitled to register the mark. The IPAB had held that FTUK did not publish a newspaper in India and therefore did not fall under the Press Act.

Arguments for the appeal are expected to take place in October.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article